• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kawaguchi Tomoya  川口 知哉

ORCIDConnect your ORCID iD *help
… Alternative Names

川口 知哉  カワグチ トモヤ

KAWAGUCHI Tomoya  川口 知哉

Less
Researcher Number 70254422
Other IDs
Affiliation (Current) 2025: 大阪公立大学, 大学院医学研究科, 教授
Affiliation (based on the past Project Information) *help 2025: 大阪公立大学, 大学院医学研究科, 教授
2018 – 2019: 大阪市立大学, 大学院医学研究科, 教授
2017: 大阪市立大学, 大学院医学研究科, 准教授
2014: 大阪市立大学, 医学部, 教授
Review Section/Research Field
Principal Investigator
Basic Section 50010:Tumor biology-related / Tumor biology
Except Principal Investigator
Clinical oncology
Keywords
Principal Investigator
発癌 / 遺伝子変異 / 肺がん / ゲノム異常 / 非小細胞肺癌 / ゲノム解析 / 環境因子 / 発がん / 肺癌
Except Principal Investigator
サイトケラチン … More / 化学療法 / FDG-PET / 薬物動態 / 薬力学 / 分子標的治療 / 癌性胸膜炎 / 非小細胞肺癌 Less
  • Research Projects

    (3 results)
  • Research Products

    (41 results)
  • Co-Researchers

    (7 People)
  •  多発発生肺がんに遺伝子変異シグネチャー解析を応用して、非喫煙者肺がんの病因を探るPrincipal Investigator

    • Principal Investigator
      川口 知哉
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50010:Tumor biology-related
    • Research Institution
      Osaka Metropolitan University
  •  Mutational analysis on carcinogenesis in multiple primary lung cancersPrincipal Investigator

    • Principal Investigator
      Kawaguchi Tomoya
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Tumor biology
    • Research Institution
      Osaka City University
  •  Nobel pharmacodynamics evaluation of molecular targeting agents: PHarmacokinetic/PHarmacodynamic Assessment on Malignant Effusions (PHAME)

    • Principal Investigator
      KUBO Akihito
    • Project Period (FY)
      2011 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Clinical oncology
    • Research Institution
      Aichi Medical University

All 2020 2019 2018 2017 2015 2014 2013 2011 Other

All Journal Article Presentation Other

  • [Journal Article] Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by <i>Stenotrophomonas maltophilia</i>2020

    • Author(s)
      Imoto Waki、Yamada Koichi、Yamairi Kazushi、Shibata Wataru、Namikawa Hiroki、Yukawa Satomi、Yoshii Naoko、Nakaie Kiyotaka、Hirose Asao、Koh Hideo、Watanabe Tetsuya、Asai Kazuhisa、Nakamae Hirohisa、Kaneko Yukihiro、Kawaguchi Tomoya、Hino Masayuki、Kakeya Hiroshi
    • Journal Title

      Intern. Med.

      Volume: 59 Issue: 2 Pages: 193-198

    • DOI

      10.2169/internalmedicine.3358-19

    • NAID

      130007785083

    • ISSN
      0918-2918, 1349-7235
    • Year and Date
      2020-01-15
    • Language
      English
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Journal Article] Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study2020

    • Author(s)
      Tamiya Akihiro、Koh Yasuhiro、Isa Shun‐ichi、Kubo Akihito、Ando Masahiko、Saka Hideo、Yoshimoto Naoki、Takeo Sadanori、Adachi Hirofumi、Tagawa Tsutomu、Kawashima Osamu、Yamashita Motohiro、Kataoka Kazuhiko、Takenoyama Mitsuhiro、Takeuchi Yukiyasu、Watanabe Katsuya、Matsumura Akihide、Kawaguchi Tomoya
    • Journal Title

      Cancer Medicine

      Volume: 9 Issue: 7 Pages: 2343-2351

    • DOI

      10.1002/cam4.2897

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K07128, KAKENHI-PROJECT-17K07176, KAKENHI-PROJECT-18K07443
  • [Journal Article] Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors2020

    • Author(s)
      Matsumoto Yoshiya、Sawa Kenji、Fukui Mitsuru、Oyanagi Jun、Yoshimoto Naoki、Suzumura Tomohiro、Watanabe Tetsuya、Kaneda Hiroyasu、Mitsuoka Shigeki、Asai Kazuhisa、Kimura Tatsuo、Yamamoto Nobuyuki、Hirata Kazuto、Koh Yasuhiro、Kawaguchi Tomoya
    • Journal Title

      Lung Cancer

      Volume: 139 Pages: 80-88

    • DOI

      10.1016/j.lungcan.2019.10.029

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Journal Article] Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor‐tyrosine kinase inhibitors in patients with EGFR ‐mutant non‐small cell lung cancer2019

    • Author(s)
      Matsumoto Yoshiya、Sawa Kenji、Fukui Mitsuru、Oyanagi Jun、Izumi Motohiro、Ogawa Koichi、Suzumura Tomohiro、Watanabe Tetsuya、Kaneda Hiroyasu、Mitsuoka Shigeki、Asai Kazuhisa、Kimura Tatsuo、Yamamoto Nobuyuki、Koh Yasuhiro、Kawaguchi Tomoya
    • Journal Title

      Cancer Science

      Volume: 110 Issue: 10 Pages: 3244-3254

    • DOI

      10.1111/cas.14156

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Journal Article] Exercise Ameliorates Emphysema Of Cigarette Smoke-Induced COPD In Mice Through The Exercise-Irisin-Nrf2 Axis.2019

    • Author(s)
      Kubo H, Asai K, Kojima K, Sugitani A, Kyomoto Y, Okamoto A, Yamada K, Ijiri N, Watanabe T, Hirata K, Kawaguchi T.
    • Journal Title

      International Journal of COPD

      Volume: 14 Pages: 2507-2516

    • DOI

      10.2147/copd.s226623

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K08660, KAKENHI-PROJECT-17K07176
  • [Journal Article] Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).2019

    • Author(s)
      Kimura T, Kawaguchi T, Chiba Y, Yoshioka H, Watanabe K, Kijima T, Kogure Y, Oguri T, Yoshimura N, Niwa T, Kasai T, Hayashi H, Ono A, Asai K, Tanaka H, Yano S, Yamamoto N, Nakanishi Y, Nakagawa K
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 49 Issue: 10 Pages: 947-955

    • DOI

      10.1093/jjco/hyz088

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K08915, KAKENHI-PROJECT-17K07176
  • [Journal Article] Astaxanthin Suppresses Cigarette Smoke-Induced Emphysema through Nrf2 Activation in Mice.2019

    • Author(s)
      Kubo H, Asai K, Kojima K, Sugitani A, Kyomoto Y, Okamoto A, Yamada K, Ijiri N, Watanabe T, Hirata K, Kawaguchi T.
    • Journal Title

      Marine Drugs

      Volume: 17 Issue: 12 Pages: 673-673

    • DOI

      10.3390/md17120673

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K08660, KAKENHI-PROJECT-17K07176
  • [Journal Article] Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy2019

    • Author(s)
      Yamamoto Norio、Watanabe Tetsuya、Yamada Kazuhiro、Nakai Toshiyuki、Suzumura Tomohiro、Sakagami Kazuki、Yoshimoto Naoki、Sato Kanako、Tanaka Hidenori、Mitsuoka Shigeki、Asai Kazuhisa、Kimura Tatsuo、Kanazawa Hiroshi、Hirata Kazuto、Kawaguchi Tomoya
    • Journal Title

      Journal of Thoracic Disease

      Volume: 11 Issue: 3 Pages: 936-943

    • DOI

      10.21037/jtd.2019.01.88

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Journal Article] Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non?small Cell Lung Cancer2018

    • Author(s)
      Yoshimura Naruo、Tada Takuhito、Matsumoto Yoshiya、Sawa Kenji、Yoshimoto Naoki、Suzumura Tomohiro、Tanaka Hidenori、Mitsuoka Shigeki、Kimura Tatsuo、Tamiya Tomohiro、Hirashima Tomonori、Kawaguchi Tomoya、Kudoh Shinzoh、Hosono Masako、Hirata Kazuto
    • Journal Title

      American Journal of Clinical Oncology

      Volume: 41 Issue: 10 Pages: 967-971

    • DOI

      10.1097/coc.0000000000000412

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Journal Article] Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysis2018

    • Author(s)
      Garassino Marina Chiara、Kawaguchi Tomoya、Gregorc Vanesa、Rulli Eliana、Ando Masahiko、Marsoni Silvia、Isa Shun-ichi、Novello Silvia、Farina Gabriella、Barni Sandro、Torri Valter、Cinquini Michela
    • Journal Title

      ESMO Open

      Volume: 3 Issue: 6 Pages: e000327-e000327

    • DOI

      10.1136/esmoopen-2018-000327

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Journal Article] Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-na?ve advanced non-squamous non-small cell lung cancer with EGFR mutations2018

    • Author(s)
      Tamiya Motohiro、Tamiya Akihiro、Shiroyama Takayuki、Takeoka Sawa、Naito Yujiro、Omachi Naoki、Kimura Yohei、Morishita Naoko、Suzuki Hidekazu、Okamoto Norio、Okishio Kyoichi、Kawaguchi Tomoya、Atagi Shinji、Hirashima Tomonori
    • Journal Title

      Investigational New Drugs

      Volume: 36 Issue: 4 Pages: 608-614

    • DOI

      10.1007/s10637-017-0527-z

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Journal Article] 肺がん薬物療法の歴史とがん免疫療法の発展2018

    • Author(s)
      川口知哉、光岡茂樹、金田裕靖、鈴村倫弘、澤兼士、渡辺徹也、浅井一久
    • Journal Title

      大阪市医学会雑誌

      Volume: 67 Pages: 7-14

    • NAID

      120006549652

    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Journal Article] Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy2017

    • Author(s)
      Tambo Yuichi、Hosomi Yukio、Sakai Hiroshi、Nogami Naoyuki、Atagi Shinji、Sasaki Yasutsuna、Kato Terufumi、Takahashi Toshiaki、Seto Takashi、Maemondo Makoto、Nokihara Hiroshi、Koyama Ryo、Nakagawa Kazuhiko、Kawaguchi Tomoya、Okamura Yuta、Nakamura Osamu、Nishio Makoto、Tamura Tomohide
    • Journal Title

      Invest New Drugs

      Volume: 35 Issue: 2 Pages: 217-226

    • DOI

      10.1007/s10637-017-0435-2

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Journal Article] PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort2017

    • Author(s)
      Sawa Kenji、Koh Yasuhiro、Kawaguchi Tomoya、Kambayashi Satoshi、Asai Kazuhisa、Mitsuoka Shigeki、Kimura Tatsuo、Yoshimura Naruo、Yoshimoto Naoki、Kubo Akihito、Saka Hideo、Matsumura Akihide、Wanibuchi Hideki、Yamamoto Nobuyuki、Nishiyama Noritoshi、Hirata Kazuto
    • Journal Title

      Lung Cancer

      Volume: 112 Pages: 96-101

    • DOI

      10.1016/j.lungcan.2017.07.039

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K07128, KAKENHI-PROJECT-17K07176, KAKENHI-PROJECT-17K09162, KAKENHI-PROJECT-15K06878, KAKENHI-PROJECT-15K09185, KAKENHI-PROJECT-15K09226
  • [Journal Article] Association between environmental tobacco smoke exposure and the occurrence of EGFR mutations and ALK-rearrangements in never-smokers with non-small cell lung cancer: analyses from a prospective multinational ETS registry.2017

    • Author(s)
      Kubo A, Soo RA, Ando M, Kawaguchi T, Ahn MJ, Ou S-HI
    • Journal Title

      Clin Lung Cancer

      Volume: 18 Issue: 5 Pages: 535-42

    • DOI

      10.1016/j.cllc.2017.01.005

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K07128, KAKENHI-PROJECT-17K07176
  • [Journal Article] Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR2017

    • Author(s)
      Watanabe Masaru、Kawaguchi Tomoya、Isa Shun-ichi、Ando Masahiko、Tamiya Akihiro、Kubo Akihito、Saka Hideo、Takeo Sadanori、Adachi Hirofumi、Tagawa Tsutomu、Kawashima Osamu、Yamashita Motohiro、Kataoka Kazuhiko、Ichinose Yukito、Takeuchi Yukiyasu、Watanabe Katsuya、Matsumura Akihide、Koh Yasuhiro
    • Journal Title

      EBioMedicine

      Volume: 21 Pages: 86-93

    • DOI

      10.1016/j.ebiom.2017.06.003

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K07128, KAKENHI-PROJECT-17K07176, KAKENHI-PROJECT-15K06878
  • [Journal Article] Reply to G Spitzer, et al; F Zhou,et al; and B Biswas.2015

    • Author(s)
      Kawaguchi T, Ando M, Kubo A.
    • Journal Title

      J Clin Oncol

      Volume: 33 Issue: 5 Pages: 526-7

    • DOI

      10.1200/jco.2014.58.5315

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314
  • [Journal Article] The role of smoking status on the progression-free survival of non-small-cell lung cancer patients harboring activating epidermal growth factor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor: a meta-analysis of prospective randomized trials.2015

    • Author(s)
      Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa S, Saka H, Kubo A, Kawaguchi T, Takada M, Rosell R, Kurata T, Ou SH.
    • Journal Title

      The Oncologist

      Volume: 20 Issue: 3 Pages: 1-9

    • DOI

      10.1634/theoncologist.2014-0285

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-15K09237, KAKENHI-PROJECT-25460896
  • [Journal Article] Ultra-sensitive detection of the pretreatment EGFR T790M mutation in non-small-cell lung cancer patients with an EGFR-activating mutation using picodroplet digital PCR.2015

    • Author(s)
      Watanabe M, Kawaguchi T, Isa S-I, Ando M, Tamiya A, Kubo A, Saka H, Takeo S, Adachi H, Tagawa T, Kakegawa S, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Sakamoto K, Matsumura A, Koh Y.
    • Journal Title

      Clin Cancer Res

      Volume: in press Issue: 15 Pages: 3552-3560

    • DOI

      10.1158/1078-0432.ccr-14-2151

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-25460896
  • [Journal Article] Long-term Complete Response in a Patient with Disseminated Pulmonary Pleomorphic Carcinoma Induced by Cisplatin and Gemcitabine2014

    • Author(s)
      Tamiya A, Asami K, Shimizu S, Matusmura A, Isa S-I, Okishio K, Kitaichi M, Atagi S, Takada M, Kawaguchi T, Kubo A.
    • Journal Title

      Intern. Med.

      Volume: 53 Issue: 22 Pages: 2625-2628

    • DOI

      10.2169/internalmedicine.53.2637

    • NAID

      130004713245

    • ISSN
      0918-2918, 1349-7235
    • Language
      English
    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23501314
  • [Journal Article] Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small cell lung cancer: Docetaxel and Erlotinib Lung cancer TriAl (DELTA).2014

    • Author(s)
      Kawaguchi T, Ando M, Asami K, Okano Y, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A.
    • Journal Title

      J Clin Oncol

      Volume: 32 Issue: 18 Pages: 1902-8

    • DOI

      10.1200/jco.2013.52.4694

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-25460896
  • [Journal Article] Long-term complete response in a patient with disseminated pulmonary pleomorphic carcinoma induced by cisplatin and gemcitabine.2014

    • Author(s)
      Tamiya A, Asami K, Shimizu S, Matusmura A, Isa S-I, Okishio K, Kitaichi M, Atagi S, Takada M, Kawaguchi T, Kubo A
    • Journal Title

      Internal Medicine (in press)

      Volume: na

    • NAID

      130004713245

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314
  • [Journal Article] Role of consolidation chemotherapy after concurrent chemo-radiotherapy in locally advanced non-small-cell lung cancer.2014

    • Author(s)
      Tsujino K, Kurata T, Kawaguchi T, Kubo A, Takada M, Ando M.
    • Journal Title

      J Thorac Oncol

      Volume: 9 Issue: 1 Pages: e7-e8

    • DOI

      10.1097/jto.0000000000000035

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-25460896
  • [Journal Article] Human papilloma virus in non-small cell lung cancer in never smokers: A systematic review of the literature.2014

    • Author(s)
      Hasegawa Y, Ando M, Kubo A, Isa SI, Yamamoto S, Tsujino K, Kurata T, Ou SH, Takada M, Kawaguchi T
    • Journal Title

      Lung Cancer

      Volume: 8 Issue: 1 Pages: 8-13

    • DOI

      10.1016/j.lungcan.2013.10.002

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-25460896
  • [Journal Article] Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small cell lung cancer: Docetaxel and Erlotinib Lung cancer TriAl (DELTA).2014

    • Author(s)
      Kawaguchi T, Ando M, Asami K, Okano Y, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A
    • Journal Title

      J Clin Oncol (in press)

      Volume: na

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314
  • [Journal Article] Rationale and Design of the Japan Molecular Epidemiology for Lung Cancer Study2013

    • Author(s)
      Kawaguchi T, Ando M, Ito N, Isa SI, Tamiya A, Shimizu S, Saka H, Kubo A, Koh Y, Matsumura A
    • Journal Title

      Clin Lung Cancer

      Volume: 14 Issue: 5 Pages: 596-600

    • DOI

      10.1016/j.cllc.2013.03.001

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-24501363, KAKENHI-PROJECT-25460896
  • [Journal Article] Rationale and design of JME study: Japan Molecular Epidemiology for lung cancer study.2013

    • Author(s)
      Kawaguchi T
    • Journal Title

      Clin Lung Cancer (in press)

      Volume: 未定

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314
  • [Journal Article] Is Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy Beneficial for Patients with Locally Advanced Non-Small-Cell Lung Cancer?: A Pooled Analysis of the Literature.2013

    • Author(s)
      Tsujino K, Kurata T, Yamamoto S, Kawaguchi T, Kubo A, Isa S, Hasegawa Y, Ou SH, Takada M, Ando M
    • Journal Title

      J Thorac Oncol

      Volume: 8 Issue: 9 Pages: 1181-9

    • DOI

      10.1097/jto.0b013e3182988348

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-25460896
  • [Presentation] Association between low-frequency pretreatment EGFR T790M mutation and tumor immune microenvironment in patients with EGFR-mutated non-small cell lung cancer.2019

    • Author(s)
      Yoshiya Matsumoto, Tomoya Kawaguchi, Yasuhiro Koh, Motohiro Izumi
    • Organizer
      American Association for Cancer Research Annual Meeting
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Presentation] Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors2018

    • Author(s)
      Yoshiya Matsumoto, Kenji Sawa, Jun Oyanagi, Mitsuru Fukui, Naoki Yoshimoto, Tomohiro Suzumura, Shigeki Mitsuoka, Kazuhisa Asai, Tatsuo Kimura, Nobuyuki Yamamoto, Tomoya Kawaguchi, Kazuto Hirata, and Yasuhiro Koh
    • Organizer
      American Association of Cancer Research
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Presentation] Japan Molecular Epidemiology for lung cancer (JME) study and beyond2018

    • Author(s)
      Tomoya Kawaguchi
    • Organizer
      The 1st Guangdong Association of Thoracic Disease Symposium for Multidisciplinary Therapy of Lung Cancer
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Presentation] Impact of de Novo T790M on Outcome for Resected NSCLC from EGFR Mutant Cohort of Japan Molecular Epidemiology (JME) Study2018

    • Author(s)
      Y. Matsumoto, T. Kawaguchi, K. Sawa, S. Isa, M. Ando, A. Tamiya, A. Kubo, H. Saka, A. Matsumura, Y. Koh
    • Organizer
      World Congress of Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Presentation] molecular epidemiology2017

    • Author(s)
      Kawaguchi t
    • Organizer
      世界肺癌学会総会
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K07176
  • [Presentation] Impacts of environmental tobacco smoke on EGFR mutations and ALK rearrangements in never smokers with non-small cell lung cancer: Analyses on a prospective multinational ETS registry.2013

    • Author(s)
      Kubo A, Ando M, Soo RA, Kawaguchi T, Ou S-HI, Ahn M-J.
    • Organizer
      15th World Conference on Lung Cancer
    • Place of Presentation
      Sydney, Australia
    • Data Source
      KAKENHI-PROJECT-23501314
  • [Presentation] Impact of environmental tobacco smoke (ETS) on ALK rearrangements in never smokers (NS) with non-small cell lung cancer (NSCLC): Analyses on a prospective multinational ETS registry.2013

    • Author(s)
      Kubo A, Ando M, Soo RA, Kawaguchi T, Ou S-HI, Ahn M-J.
    • Organizer
      Annual Meeting of the American Society of Clinical Oncology
    • Place of Presentation
      Chicago, IL, USA
    • Data Source
      KAKENHI-PROJECT-23501314
  • [Presentation] Randomized phase III trial of erlotinib (E) versus (v) docetaxel (D) as second or third line therapy in patients with advanced non-small cell lung cancer (NSCLC) who have wild type or mutant epidermal growth factor receptor (EGFR): Docetaxel and Erlotinib Lung cancer TriAl (DELTA).2013

    • Author(s)
      Okano Y, Ando M, Asami K, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A, Kawaguchi T.
    • Organizer
      Annual Meeting of the American Society of Clinical Oncology
    • Place of Presentation
      Chicago, IL, USA
    • Data Source
      KAKENHI-PROJECT-23501314
  • [Presentation] 非小細胞肺癌(NSCLC)の癌性胸膜炎(MPE)におけるゲフィチニブの薬力学・薬物動態・臨床第II相試験2011

    • Author(s)
      久保昭仁、洪 泰浩、堀 隆、伊佐俊一、福岡順也、川口知哉、安藤昌彦、岡本 勇、北市正則、安宅信二、河原正明、楠 洋子、山口悦郎、中川和彦、高田 實
    • Organizer
      第51回日本呼吸器学会学術講演会
    • Place of Presentation
      東京
    • Data Source
      KAKENHI-PROJECT-23501314
  • [Presentation] Updated overall survival (OS) results of randomized phase III trial of erlotinib (E) versus (v) docetaxel (D) as second or third line therapy in patients with advanced non-small cell lung cancer (NSCLC): Docetaxel and Erlotinib Lung cancer TriAl (DELTA).

    • Author(s)
      Ibata H, Ando M, Asami K, Okano Y, Fukuda M, Nakagawa H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A, Kawaguchi T.
    • Organizer
      Annual Meeting of the American Society of Clinical Oncology
    • Place of Presentation
      Chicago, IL, USA.
    • Year and Date
      2014-05-30 – 2014-06-03
    • Data Source
      KAKENHI-PROJECT-23501314
  • [Presentation] The role of smoking status on the progression-free survival of non-small-cell lung cancer patients harboring activating epidermal growth factor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor: a meta-analysis of prospective randomized trials.

    • Author(s)
      Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa S, Saka H, Kubo A, Kawaguchi T, Takada M, Kurata T, Ou SH.
    • Organizer
      Annual Meeting of the American Society of Clinical Oncology
    • Place of Presentation
      Chicago, IL, USA.
    • Year and Date
      2014-05-30 – 2014-06-03
    • Data Source
      KAKENHI-PROJECT-23501314
  • []

  • []

  • 1.  KOU Yasuhiro (80426519)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 11 results
  • 2.  KUBO Akihito (60416245)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 20 results
  • 3.  FUKUOKA Junya (00324575)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 4.  TAKADA Minoru (20373516)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 11 results
  • 5.  ISA Shun-Ichi (60421913)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 12 results
  • 6.  ASAI Kazuhisa
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 7.  KIMURA Tatsuo
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi